Literature DB >> 27291995

Olaratumab in soft-tissue sarcomas.

Winette T A van der Graaf1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27291995     DOI： 10.1016/S0140-6736(16)30788-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.

Authors:  Qing Wu; Wei Qian; Xiaoli Sun; Shaojie Jiang
Journal:  J Hematol Oncol       Date:  2022-10-08       Impact factor: 23.168

Review 2.  New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.

Authors:  Isabel Corraliza-Gorjón; Beatriz Somovilla-Crespo; Silvia Santamaria; Jose A Garcia-Sanz; Leonor Kremer
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

3.  Investigating a chimeric anti-mouse PDGFRα antibody as a radiosensitizer in primary mouse sarcomas.

Authors:  Erin J Song; Kathleen A Ashcraft; Caitlin D Lowery; Yvonne M Mowery; Lixia Luo; Yan Ma; Lorraine Da Silva Campos; Diana M Cardona; Louis Stancato; David G Kirsch
Journal:  EBioMedicine       Date:  2019-01-31       Impact factor: 8.143
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.